Document Details
Form
Filing Date
Mar 03, 2020
Document Date
Feb 28, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
Mazzo David J
